APA (7th ed.) Citation

H, I., K, K., M, T., S, N., Y, A., H, K., . . . A, O. (2023). Long-term efficacy of nusinersen and its evaluation in adolescent and adult patients with spinal muscular atrophy types 1 and 2. Brain & development, 45(2), 110. https://doi.org/10.1016/j.braindev.2022.10.006

Chicago Style (17th ed.) Citation

H, Iwayama, et al. "Long-term Efficacy of Nusinersen and Its Evaluation in Adolescent and Adult Patients with Spinal Muscular Atrophy Types 1 and 2." Brain & Development 45, no. 2 (2023): 110. https://doi.org/10.1016/j.braindev.2022.10.006.

MLA (9th ed.) Citation

H, Iwayama, et al. "Long-term Efficacy of Nusinersen and Its Evaluation in Adolescent and Adult Patients with Spinal Muscular Atrophy Types 1 and 2." Brain & Development, vol. 45, no. 2, 2023, p. 110, https://doi.org/10.1016/j.braindev.2022.10.006.